Chromadex Net Income 2024

Chromadex Net Income

-255,797.95 USD

Chromadex Dividend yield

Ticker

CDXC

ISIN

US1710774076

WKN

A2AG5N

In 2024, Chromadex's profit amounted to -255,797.95 USD, a -94.82% increase from the -4.94 M USD profit recorded in the previous year.

The Chromadex Net Income history

YEARNET INCOME (undefined USD)
2026e-10.53
2025e6.53
2024e-0.26
2023-4.94
2022-16.54
2021-27.13
2020-19.93
2019-32.15
2018-33.32
2017-11.38
2016-2.93
2015-2.77
2014-5.39
2013-4.42
2012-11.66
2011-7.89
2010-2.05
2009-0.91
2008-2.1
2007-0.19
2006-

Chromadex Aktienanalyse

What does Chromadex do?

The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Chromadex's Profit Margins

The profit margins of Chromadex represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Chromadex's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Chromadex's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Chromadex's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Chromadex’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Chromadex Stock

How much profit has Chromadex made this year?

Chromadex has made -255,797.95 USD this year.

How has the profit developed compared to last year?

The profit has increased by -94.82% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Chromadex publish its earnings?

Chromadex publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Chromadex?

The profits of Chromadex are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Chromadex?

You can learn more about the earnings of Chromadex by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Chromadex pay?

Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.

What is the dividend yield of Chromadex?

The current dividend yield of Chromadex is .

When does Chromadex pay dividends?

Chromadex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chromadex?

Chromadex paid dividends every year for the past 0 years.

What is the dividend of Chromadex?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chromadex located?

Chromadex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chromadex from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Chromadex pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Chromadex in the year 2023?

In the year 2023, Chromadex distributed 0 USD as dividends.

In which currency does Chromadex pay out the dividend?

The dividends of Chromadex are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Chromadex stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Chromadex

Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.